-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Li Zhihong, Vice Chairman of the Standing Committee of the Shijiazhuang Municipal People’s Congress, Conducts Research Visit to Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Category:
发布时间：2020-05-27
【概要描述】
On May 26, Li Zhihong, Vice Chairman of the Standing Committee of the Shijiazhuang Municipal People’s Congress, visited Shijiazhuang Sihua Pharmaceutical Co., Ltd. to conduct an inspection of the company’s routine epidemic prevention and control measures as well as its resumption and full-capacity production.
On May 26, Li Zhihong, Vice Chairman of the Standing Committee of the Shijiazhuang Municipal People’s Congress, visited Shijiazhuang Sihua Pharmaceutical Co., Ltd. to conduct an inspection of the company’s routine epidemic prevention and control measures as well as its resumption and full-capacity production.
“How are production and operations going? Have you encountered any difficulties? What kind of support do you need?” Li Zhihong inquired with genuine concern about the company’s current production and operational status. Su Xuejun, Chairman of the company, provided a detailed briefing to Li Zhihong and his delegation on the enterprise’s present production and operational performance. Since the onset of the pandemic, Shijiazhuang Sihua Pharmaceutical has rigorously implemented the directives and requirements issued by the Municipal Party Committee and the Municipal Government, strengthened organizational safeguards, and meticulously planned and deployed measures for epidemic prevention and control as well as for resuming work and production, thereby ensuring that both epidemic prevention and safe production have been effectively maintained.
After listening to the relevant briefing, Li Zhihong commended Shijiazhuang Sihua Pharmaceutical for its meticulous and solid epidemic prevention and control efforts, and expressed appreciation for the company’s proactive measures in overcoming adverse factors to accelerate its development. The epidemic prevention and control work has been rigorous and effective, and the resumption of work and production is proceeding steadily and in an orderly manner. Li Zhihong emphasized the need to continue attaching great importance to epidemic prevention and control, maintaining unwavering vigilance, proactively addressing current challenges, bolstering confidence, focusing on targeted and precise actions, rising to difficulties, and contributing to the promotion of high-quality regional economic development.
Jin Kerui, a member of the Working Committee of the High-tech Zone, Zhang Wei, Deputy Director of the Bureau of Social Development of the High-tech Zone, and other relevant leaders attended the research visit.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091